HOME >> BIOLOGY >> NEWS
Activated signaling pathway may predict lung cancer patients' response to gefitinib

There are multiple signaling pathways in a cell that control its behavior, such as the ability to survive and divide rapidly. A new study in the August 4 issue of the Journal of the National Cancer Institute has found that, among patients with nonsmall-cell lung cancer (NSCLC) whose tumor cells contain a specific activated signaling pathway, the cancer drug gefitinib (Iressa) was associated with a better response rate, disease control rate, and time to progression compared with patients in whom the pathway was not activated.

NSCLC is the most common type of lung cancer. Less than 15% of patients with NSCLC are cured despite aggressive surgical and chemotherapeutic intervention. Gefitinib, a cancer drug that interferes with the epidermal growth factor receptor (EGFR) pathway, is active in approximately 10% of NSCLC patients in whom standard therapy has failed. Although earlier studies have found that the expression of EGFR alone does not predict whether a patient will respond to gefitinib, there are many signaling pathways that are dependent on EGFR expression.

To determine whether two such pathways--called Akt and MAPK--may be involved in a patient's response to gefitinib, Federico Cappuzzo, M.D., of Bellaria Hospital in Bologna, Italy, and colleagues, looked at the association between phosphorylation status (a measure of activation) of Akt and MAPK in tumors from 103 patients with NSCLC before they received treatment and any subsequent response to gefitinib.

The authors found that 51 patients had tumors that were positive for Akt phosphorylation (P-Akt). P-Akt positivity was associated with being female and having a history of never smoking. Patients with P-Aktpositive tumors had a better response rate, disease control rate (which includes complete and partial responses and stable disease), and time to progression than patients with P-Akt negative tumors. There was no difference in outcome according to MAPK phosyphorylation (P-MAPK)
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
3-Aug-2004


Page: 1 2

Related biology news :

1. NRH1 and Wnt signaling come together in convergent extension
2. From lung to gut the Wnt signaling pathway transforms cell fate
3. Equine clonings triple play sheds light on calcium, cell signaling, human disease
4. UT Southwestern researchers learn importance of insulin family signaling in male sex determination
5. Mantis shrimp fluoresce to enhance signaling in the dim ocean depths
6. OHSU researchers discover molecular signaling system controlling aspects of embryonic development
7. New study identifies gene signaling puberty
8. Are the bright colors of some avian eggs signaling female genetic quality to their mates?
9. Scientists map signaling molecule crucial to survival, disease
10. Researchers identify molecular signaling system that is crucial for plant fertility
11. Plants and people share a molecular signaling system, researchers discover

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/7/2019)... ... May 07, 2019 , ... Landsec and Spartan ... in the UK. , In May, Landsec will undertake trials using Spartan’s innovative ... enabling operators to take corrective action within hours instead of weeks. This ...
(Date:5/2/2019)... ... April 30, 2019 , ... Global molecular diagnostics ... that Holotype HLA and other Omixon products will be featured in 12 poster ... in Lisbon, Portugal. Among the major scientific events, Omixon’s Lunch Symposium ...
(Date:4/27/2019)... (PRWEB) , ... April 26, ... ... flagship market research study " 2019 Global Assessment Report: The Laboratory Analytical ... product categories is presented in 10 sections that include chromatography, life science ...
Breaking Biology News(10 mins):
(Date:5/2/2019)... ... April 30, 2019 , ... ... standard, REPROCELL USA Inc. has demonstrated its ability to provide various services ... aims to enhance customer satisfaction through the effective implementation of its quality ...
(Date:5/2/2019)... BOSTON (PRWEB) , ... May 02, 2019 , ... ... hair transplantation clinic in the greater Boston area. Gone are the days of ... The ARTAS® iX Robotic Hair Restoration System is the only robotic intelligent solution ...
(Date:4/16/2019)... ... 16, 2019 , ... On April 24th, the Federal Laboratory ... Center for Environmental Health Research (USACEHR), with an award for their cooperative effort ... veteran-owned company located at the Frederick Innovative Technology Center, Inc. (FITCI) on Metropolitan ...
(Date:4/10/2019)... ... April 10, 2019 , ... ... technology leaders, have locked into multiple agreements to help companies advance their ... regenerative medicine industry, ranging from synthetic biology companies that are gene editing ...
Breaking Biology Technology:
Cached News: